Basit öğe kaydını göster

Clinical Benefits of First-Line (1L) Cemiplimab Monotherapy by PD-L1 Expression Levels in Patients With Advanced NSCLC

dc.contributor.authorGladkov, O.
dc.contributor.authorKilickap, S.
dc.contributor.authorSezer, A.
dc.contributor.authorGumus, M.
dc.contributor.authorBondarenko, I.
dc.contributor.authorOzguroglu, M.
dc.contributor.authorGogishvili, M.
dc.contributor.authorTurk, H. M.
dc.contributor.authorCicin, I.
dc.contributor.authorBentsion, D.
dc.contributor.authorClingan, P.
dc.contributor.authorSriuranpong, V.
dc.contributor.authorRizvi, N.
dc.contributor.authorLi, S.
dc.contributor.authorLee, S.
dc.contributor.authorMakharadze, T.
dc.contributor.authorPaydas, S.
dc.contributor.authorNechaeva, M.
dc.contributor.authorSeebach, F.
dc.contributor.authorWeinreich, D. M.
dc.contributor.authorYancopoulos, G. D.
dc.contributor.authorGullo, G.
dc.contributor.authorLowy, I.
dc.contributor.authorRietschel, P.
dc.date.accessioned2021-12-10T11:14:57Z
dc.date.available2021-12-10T11:14:57Z
dc.date.issued2021
dc.identifier.citationKilickap S., Sezer A., Gumus M., Bondarenko I., Ozguroglu M., Gogishvili M., Turk H. M. , Cicin I., Bentsion D., Gladkov O., et al., "Clinical Benefits of First-Line (1L) Cemiplimab Monotherapy by PD-L1 Expression Levels in Patients With Advanced NSCLC", JOURNAL OF THORACIC ONCOLOGY, cilt.16, sa.3, 2021
dc.identifier.issn1556-0864
dc.identifier.othervv_1032021
dc.identifier.otherav_72070c97-9094-4ed3-8ded-cf22531b3841
dc.identifier.urihttp://hdl.handle.net/20.500.12627/171524
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectGöğüs Hastalıkları ve Allerji
dc.subjectSOLUNUM SİSTEMİ
dc.subjectOnkoloji
dc.subjectOncology
dc.subjectRespiratory Care
dc.subjectPulmonary and Respiratory Medicine
dc.subjectONKOLOJİ
dc.subjectHealth Sciences
dc.subjectİç Hastalıkları
dc.titleClinical Benefits of First-Line (1L) Cemiplimab Monotherapy by PD-L1 Expression Levels in Patients With Advanced NSCLC
dc.typeMakale
dc.relation.journalJOURNAL OF THORACIC ONCOLOGY
dc.contributor.departmentHacettepe Üniversitesi , ,
dc.identifier.volume16
dc.identifier.issue3
dc.contributor.firstauthorID2622094


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster